| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,676 |
6,763 |
$724K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,620 |
5,069 |
$475K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,669 |
5,948 |
$437K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,158 |
2,828 |
$400K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,077 |
1,542 |
$239K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
424 |
359 |
$106K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,121 |
1,833 |
$82K |
| 99051 |
|
6,914 |
6,302 |
$38K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
567 |
481 |
$31K |
| 87529 |
|
900 |
669 |
$26K |
| 87481 |
|
1,179 |
870 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,198 |
899 |
$22K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,178 |
884 |
$22K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
8,464 |
7,647 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
792 |
716 |
$13K |
| 87640 |
|
623 |
451 |
$11K |
| 99072 |
|
4,280 |
3,766 |
$10K |
| 87581 |
|
466 |
390 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
559 |
479 |
$9K |
| 87486 |
|
448 |
378 |
$9K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
501 |
339 |
$9K |
| 87563 |
|
294 |
276 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
1,889 |
1,636 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
339 |
315 |
$5K |
| 87653 |
|
365 |
214 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
196 |
175 |
$4K |
| 90716 |
|
27 |
27 |
$4K |
| 87511 |
|
303 |
219 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
52 |
51 |
$3K |
| 90746 |
|
50 |
43 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
156 |
145 |
$3K |
| 80053 |
Comprehensive metabolic panel |
417 |
358 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
134 |
126 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
460 |
389 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
59 |
41 |
$2K |
| 87541 |
|
90 |
82 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
125 |
101 |
$2K |
| 90674 |
|
52 |
48 |
$2K |
| 81003 |
|
1,072 |
867 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
52 |
44 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
105 |
45 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
25 |
22 |
$1K |
| 90707 |
|
12 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
88 |
78 |
$1K |
| 90756 |
|
35 |
32 |
$722.83 |
| 90715 |
|
13 |
13 |
$501.15 |
| 90713 |
|
12 |
12 |
$463.20 |
| 99000 |
|
1,824 |
1,633 |
$318.68 |
| 87500 |
|
20 |
13 |
$301.74 |